Drug targets are identified through a combination of basic research, computational biology, and clinical studies. Techniques such as genomic sequencing, proteomics, and bioinformatics are pivotal. Researchers study the genetic and molecular profiles of cancer cells to pinpoint abnormalities that could be exploited therapeutically.
